港股異動 | 華檢醫療(1931.HK)放量大漲近11% 公司採納股份獎勵計劃
格隆匯5月21日丨華檢醫療(01931.HK)盤初一度急升至12%,現放量大漲10.86%,報3.27港元,暫成交2293萬港元,最新總市值46億港元。華檢醫療日前宣佈,其已採納股份獎勵計劃,而集團全體僱員均有資格參加該計劃。根據該計劃可向獲選僱員授出的最高股份數目不得超過公司不時已發行股本的1%。另外,公司2019年淨利大增165.9%至2.75億元。近期醫療設備股持續強勢,微創醫療、 永勝醫療等皆有漲幅。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.